tiprankstipranks

James G. Bender Insider Profile

4 Followers
James G. Bender, VP, Manufacturing at Iovance Biotherapeutics, holds 88.73K shares in Iovance Biotherapeutics (Ticker: IOVA), holds 100.00 shares in ImmunoCellular Therapeutics (Ticker: IMUC).
tipranks
James G. Bender

James G. Bender
Iovance Biotherapeutics (IOVA)
VP, Manufacturing

Ranked #17,548 out of 98,909 Corporate Insiders

Profitable Transactions

100%
3 out of 3 Profitable Transactions

Average Return

+44.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$909K
100.00%
<0.01%
A breakdown of James G. Bender's holdings

Insider Roles

Iovance Biotherapeutics
(IOVA)
VP, Manufacturing
ImmunoCellular Therapeutics
(IMUC)
VP, Product Development & Mfg.
Roles that James G. Bender holds in companies

Most Profitable Insider Trade

Stock:
ImmunoCellular Therapeutics
(IMUC)
Rating:Informative Sell
Date:Aug 30, 2013 - Aug 30, 2014
Return:+65.20%
The most profitable trade made by James G. Bender

James G. Bender's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Iovance Biotherapeutics
Dec 30, 2015
VP, Manufacturing
Uninformative Sell
64.94K
$908.55K
ImmunoCellular Therapeutics
Aug 30, 2013
VP, Product Development & Mfg.
Informative Sell
59.71K
$19.90
List of latest transactions for each holding click on a transaction to see James G. Bender's performance on stock

James G. Bender insider profile FAQ

What is the percentage of profitable transactions made by James G. Bender?
The percentage of profitable transactions made by James G. Bender is 100%.
    What is the average return per transaction made by James G. Bender?
    The average return per transaction made by James G. Bender is 44.00%.
      What stocks does James G. Bender hold?
      James G. Bender holds: IOVA, IMUC stocks.
        What was James G. Bender’s latest transaction?
        James G. Bender latest transaction was an Uninformative Sell of $64.94K.
          What was James G. Bender's most profitable transaction?
          James G. Bender’s most profitable transaction was an Informative Sell of IMUC stock on August 30, 2013. The return on the trade was 65.20%.
            What is James G. Bender's role in Iovance Biotherapeutics?
            James G. Bender's role in Iovance Biotherapeutics is VP, Manufacturing.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.